Sign in

CIK 0001593899 · Non-accelerated filer<br>Smaller reporting company

Atea Pharmaceuticals, Inc.

Sign in to watch
Ticker
AVIR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
operating
EIN
460574869
Phone
(857) 284-8891
Business address
225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G Stake Amended Statement of Ownership
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 8-K Event Regulation FD disclosure
  15. 4 Open-market buy Director bought 12,000 shares at $8.57 ($102,796)
  16. SC 13G Stake Amended Statement of Ownership
  17. 8-K Event Regulation FD disclosure
  18. S-3ASR Offering Registration Statement
  19. 8-K Event Agreement ended
  20. 10-Q Report Quarterly Report

Page 11 of 16 · 316 filings